MRL Ventures Fund
MRL Ventures Fund offers investement funds to therapeutics companies to enhance patients care.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed MRL Ventures Fund Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$19M
Raised Total:$19M
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
MRL Ventures Fund offers investement funds to therapeutics companies to enhance patients care.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 2/2022 | Eyebiotech | Series A | 0 |
| 12/2018 | Entrada Therapeutics | Series A | 59M |
| 10/2019 | LabCentral | Corporate Round | 13M |
| 11/2018 | Kymera Therapeutics | Series B | 65M |
| 5/2021 | Therini Bio | Seed Round | 0 |
| 10/2014 | Imago BioSciences | Series A | 26.5M |
| 1/2021 | LifeMine Therapeutics | Series B | 0 |
| 2/2021 | Xilio Therapeutics | Series C | 95M |
| 11/2018 | Caraway Therapeutics | Series A | 23M |
| 2/2016 | Spero Therapeutics | Series B | 30M |
| 11/2015 | Viridian Therapeutics | Series C | 0 |
| 5/2020 | HotSpot Therapeutics | Series B | 65M |
| 10/2017 | Visterra | Series C | 0 |
| 3/2021 | Carisma Therapeutics | Series B | 0 |
| 11/2020 | Imago BioSciences | Series C | 80M |
| 3/2019 | Imago BioSciences | Series B | 40M |
| 9/2017 | LifeMine Therapeutics | Series A | 0 |
| 12/2020 | Tallac Therapeutics | Series A | 62M |
| 1/2022 | AmbAgon Therapeutics | Series A | 0 |
| 7/2015 | Translate Bio | Series B | 0 |
| 3/2021 | Entrada Therapeutics | Series B | 0 |
| 1/2016 | Alector | Series D | 29.5M |
| 3/2022 | LifeMine Therapeutics | Series C | 0 |
| 9/2022 | Photys | Series A | 0 |
| 1/2017 | Translate Bio | Series C | 51M |
| 4/2023 | Therini Bio | Series A | 0 |
| 5/2023 | Ray Therapeutics | Series A | 0 |
| 8/2022 | Aktis Oncology | Series A | 0 |
| 7/2021 | PAQ Therapeutics | Series A | 0 |
| 1/2021 | Carisma Therapeutics | Series B | 0 |
| 3/2020 | Xilio Therapeutics | Series B | 100.5M |
| 9/2020 | Lava Therapeutics | Series C | 83M |
| 6/2018 | Carisma Therapeutics | Series A | 0 |
| 9/2022 | Carisma Therapeutics | Series C | 0 |
| 3/2017 | Spero Therapeutics | Series C | 51.7M |
| 9/2015 | Alector | Series C | 32M |
| 10/2021 | Mozart Therapeutics | Series A | 0 |
| 1/2020 | Caraway Therapeutics | Venture Round | - |
| 7/2018 | Alector | Series E | 133M |
| 4/2023 | Therini Bio | Series A | 0 |
| 9/2022 | Carisma Therapeutics | Series C | 0 |
| 9/2022 | Photys Therapeutics | Series A | 0 |
| 8/2022 | Aktis Oncology | Series A | 0 |
| 3/2022 | LifeMine Therapeutics | Series C | 0 |
| 2/2022 | Eyebiotech | Series A | 0 |
| 1/2022 | AmbAgon Therapeutics | Series A | 0 |
| 10/2021 | Mozart Therapeutics | Series A | 0 |
| 7/2021 | PAQ Therapeutics | Series A | 0 |
| 5/2021 | Therini Bio | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
